Follow-The-Filings

ALNY · Alnylam Pharmaceuticals Inc.

Q3 2019 13F holders

← latest ownership dossier

Ticker
ALNY
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares